Stay updated on Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T12:29:59.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:23:07.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer revision number changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:15:22.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study record content. This indicates an access restriction or server-side issue preventing viewing the NCT03276013 details.
    Difference
    17%
    Check dated 2026-09-20T15:35:25.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a new build/version of the page.
    Difference
    0.1%
    Check dated 2026-08-29T23:58:13.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    A new page revision label v3.6.5 was added, replacing the previous revision v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-08T23:26:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.